ES2169467T3 - Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento. - Google Patents
Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento.Info
- Publication number
- ES2169467T3 ES2169467T3 ES98117529T ES98117529T ES2169467T3 ES 2169467 T3 ES2169467 T3 ES 2169467T3 ES 98117529 T ES98117529 T ES 98117529T ES 98117529 T ES98117529 T ES 98117529T ES 2169467 T3 ES2169467 T3 ES 2169467T3
- Authority
- ES
- Spain
- Prior art keywords
- bifenilsulfonilcianamidas
- procedure
- preparation
- medicinal product
- ischemically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000035778 pathophysiological process Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LOS COMPUESTOS DE LA FORMULA I, EN LOS CUALES LOS SIMBOLOS TIENEN LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES, POSEEN PROPIEDADES ESPECIALES ANTIARRITMICAS Y TIENEN UN COMPONENTE CARDIOPROTECTOR. SE PUEDEN, DE MANERA PREVENTIVA, INHIBIR O IMPEDIR LOS PROCESOS PATOFISIOLOGICOS CON LA APARICION DE DAÑOS INDUCIDOS ISQUEMICAMENTE, EN PARTICULAR CUANDO SE PRODUCEN ARRITMIAS CARDIACAS INDUCIDAS ISQUEMICAMENTE. ADEMAS TIENEN UN FUERTE EFECTO INHIBIDOR EN LA PROLIFERACION DE CELULAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19741635A DE19741635A1 (de) | 1997-09-22 | 1997-09-22 | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2169467T3 true ES2169467T3 (es) | 2002-07-01 |
Family
ID=7843124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98117529T Expired - Lifetime ES2169467T3 (es) | 1997-09-22 | 1998-09-16 | Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5968978A (es) |
EP (1) | EP0903339B1 (es) |
JP (1) | JP4272278B2 (es) |
KR (1) | KR19990029983A (es) |
CN (2) | CN1212255A (es) |
AR (1) | AR015170A1 (es) |
AT (1) | ATE210638T1 (es) |
AU (1) | AU755553B2 (es) |
BR (1) | BR9803968A (es) |
CA (1) | CA2247749A1 (es) |
CZ (1) | CZ300698A3 (es) |
DE (2) | DE19741635A1 (es) |
DK (1) | DK0903339T3 (es) |
ES (1) | ES2169467T3 (es) |
HK (1) | HK1040980A1 (es) |
HU (1) | HUP9802132A3 (es) |
PL (1) | PL328762A1 (es) |
PT (1) | PT903339E (es) |
TR (1) | TR199801871A2 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19737224A1 (de) * | 1997-08-27 | 1999-03-18 | Hoechst Marion Roussel De Gmbh | Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
DE19804251A1 (de) | 1998-02-04 | 1999-08-05 | Hoechst Marion Roussel De Gmbh | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
BR9908474A (pt) * | 1998-03-04 | 2000-12-05 | Takeda Chemical Industries Ltd | Preparação de liberação prolongada, processo para a produção de uma preparação de liberação prolongada, e, composição farmacêutica |
DE19820064A1 (de) * | 1998-05-06 | 1999-11-11 | Hoechst Marion Roussel De Gmbh | Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
IL140905A0 (en) * | 1998-07-20 | 2002-02-10 | Smithkline Beecham Corp | Bioenhanced formulations comprising eprosartan in oral solid dosage form |
DE10018401A1 (de) * | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
AU2002336650B2 (en) | 2001-10-25 | 2008-06-05 | Emory University | Catheter for modified perfusion |
US20070160645A1 (en) * | 2001-10-25 | 2007-07-12 | Jakob Vinten-Johansen | PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs |
DE10206354A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen |
US20040138306A1 (en) * | 2002-07-25 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
US20060099230A1 (en) * | 2004-11-10 | 2006-05-11 | Chin-Chih Chiang | Novel formulations of eprosartan with enhanced bioavailability |
JP2008525468A (ja) * | 2004-12-22 | 2008-07-17 | エモリー・ユニバーシティ | ポストコンディショニング臓器保護作用を増強する治療補助薬 |
EP1762179A1 (en) * | 2005-09-07 | 2007-03-14 | Boehringer Ingelheim Vetmedica Gmbh | Method for improving diagnostic quality in echocardiography |
US7541492B2 (en) * | 2005-10-26 | 2009-06-02 | Toyota Jidosha Kabushiki Kaisha | Perfluoroalkanesulfonamide compounds |
KR20140057604A (ko) | 2011-08-12 | 2014-05-13 | 베링거잉겔하임베트메디카게엠베하 | 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제 |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
CN113527152B (zh) * | 2021-08-09 | 2023-07-28 | 西北农林科技大学 | 一种联苯磺酰胺类化合物及其防治农作物害虫的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2533127A1 (de) * | 1975-07-24 | 1977-02-10 | Bayer Ag | Polytriazine und ein verfahren zu deren herstellung |
DE2533126A1 (de) * | 1975-07-24 | 1977-02-10 | Bayer Ag | Polytriazine und ein verfahren zu deren herstellung |
CA2062558A1 (en) * | 1991-03-08 | 1992-09-09 | Prasun K. Chakravarty | Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists |
EP0503838A3 (en) * | 1991-03-08 | 1992-10-07 | Merck & Co. Inc. | Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists |
WO1992020662A1 (en) * | 1991-05-10 | 1992-11-26 | Merck & Co., Inc. | Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
EP0855392A3 (de) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1997
- 1997-09-22 DE DE19741635A patent/DE19741635A1/de not_active Withdrawn
-
1998
- 1998-09-16 EP EP98117529A patent/EP0903339B1/de not_active Expired - Lifetime
- 1998-09-16 PT PT98117529T patent/PT903339E/pt unknown
- 1998-09-16 ES ES98117529T patent/ES2169467T3/es not_active Expired - Lifetime
- 1998-09-16 DK DK98117529T patent/DK0903339T3/da active
- 1998-09-16 DE DE59802412T patent/DE59802412D1/de not_active Expired - Lifetime
- 1998-09-16 AT AT98117529T patent/ATE210638T1/de not_active IP Right Cessation
- 1998-09-18 CZ CZ983006A patent/CZ300698A3/cs unknown
- 1998-09-18 AR ARP980104685A patent/AR015170A1/es unknown
- 1998-09-21 KR KR1019980038932A patent/KR19990029983A/ko not_active Application Discontinuation
- 1998-09-21 BR BR9803968-7A patent/BR9803968A/pt not_active IP Right Cessation
- 1998-09-21 JP JP26685098A patent/JP4272278B2/ja not_active Expired - Fee Related
- 1998-09-21 US US09/157,589 patent/US5968978A/en not_active Expired - Lifetime
- 1998-09-21 AU AU86108/98A patent/AU755553B2/en not_active Ceased
- 1998-09-21 CA CA002247749A patent/CA2247749A1/en not_active Abandoned
- 1998-09-21 TR TR1998/01871A patent/TR199801871A2/xx unknown
- 1998-09-22 CN CN98119536A patent/CN1212255A/zh active Pending
- 1998-09-22 HU HU9802132A patent/HUP9802132A3/hu unknown
- 1998-09-22 PL PL98328762A patent/PL328762A1/xx unknown
-
2000
- 2000-02-25 CN CN00102661A patent/CN1326928A/zh active Pending
-
2002
- 2002-04-03 HK HK02102461.4A patent/HK1040980A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JPH11189581A (ja) | 1999-07-13 |
AU755553B2 (en) | 2002-12-12 |
PL328762A1 (en) | 1999-03-29 |
EP0903339B1 (de) | 2001-12-12 |
HUP9802132A3 (en) | 2000-04-28 |
AR015170A1 (es) | 2001-04-18 |
CN1212255A (zh) | 1999-03-31 |
DK0903339T3 (da) | 2002-04-08 |
CA2247749A1 (en) | 1999-03-22 |
AU8610898A (en) | 1999-04-01 |
EP0903339A3 (de) | 1999-03-31 |
EP0903339A2 (de) | 1999-03-24 |
JP4272278B2 (ja) | 2009-06-03 |
TR199801871A3 (tr) | 1999-04-21 |
HUP9802132A2 (hu) | 2000-02-28 |
CN1326928A (zh) | 2001-12-19 |
HU9802132D0 (en) | 1998-11-30 |
CZ300698A3 (cs) | 1999-04-14 |
PT903339E (pt) | 2002-06-28 |
HK1040980A1 (zh) | 2002-06-28 |
US5968978A (en) | 1999-10-19 |
ATE210638T1 (de) | 2001-12-15 |
BR9803968A (pt) | 2000-05-02 |
TR199801871A2 (xx) | 1999-04-21 |
KR19990029983A (ko) | 1999-04-26 |
DE59802412D1 (de) | 2002-01-24 |
DE19741635A1 (de) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2169467T3 (es) | Bifenilsulfonilcianamidas, procedimiento para su preparacion y su utilizacion como medicamento. | |
BRPI0410888A (pt) | uso de derivados de difenilmetano como inibidores de tirosinase | |
ES2124793T3 (es) | Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores. | |
AR020345A1 (es) | Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones. | |
CL2010000658A1 (es) | Mezcla fungicida que contiene protioconazol o sus derivados,en combinación con los derivados de estrobirulina,trifloxiestrobina,picoestrobina,piracloestrobina y dimoxiestrobina. | |
TR200102020T2 (tr) | Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler. | |
ECSP003591A (es) | Antibacterianos | |
ES2139877T3 (es) | Agente anti-incrustacion. | |
ECSP067093A (es) | Derivados de sulfamato y sulfamida para el tratamiento de epilepsia y trastornos relacionados | |
PA8468401A1 (es) | Compuestos para el tratamiento de la isquemia | |
CO5271715A1 (es) | 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa | |
ECSP034896A (es) | Derivados aromaticos de acidos dicarboxilicos | |
GT199900102A (es) | Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen. | |
AR010385A1 (es) | Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto. | |
AR043985A1 (es) | Tratamiento terapeutico de la constipacion | |
BR9406080A (pt) | Compostos que tem tanto antividade de anaonista potente de calcio como de antioxidante e uso dos mesmos como agentes citoprotetores | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ECSP109852A (es) | Uso de homo y copolímeros para la estabilización de formulaciones de principios activos | |
AR047070A1 (es) | Derivados de difenilazetidona | |
AR050235A1 (es) | Formulacion agroquimica que contiene un herbicida inhibidor de la hppd y una cloroacetamida | |
AR025951A1 (es) | Derivados de 4-hicroxibifenil hidrazidas y métodos para preparar los derivados. | |
UY26895A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
AR031601A1 (es) | Derivados de 4-pirimidinamina, composiciones farmaceuticas y metodos relacionados | |
AR052048A1 (es) | Composiciones farmaceuticas para el tratamiento de la celulitis | |
BRPI0408499A (pt) | solução aquosa estável de um fungicida de polieno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 903339 Country of ref document: ES |